|
HS Code |
408161 |
| Productname | 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile |
| Molecularformula | C13H7FN4O |
| Molecularweight | 254.22 g/mol |
| Casnumber | 1447966-35-9 |
| Appearance | Solid |
| Solubility | DMSO, DMF |
| Purity | ≥98% (HPLC) |
| Storagecondition | Store at 2-8°C |
| Smiles | C1=CC(=NC=C1C2=CC(=NN3C2=CC=C3O)C#N)F |
| Inchikey | CLBYFZYFGDGRDM-UHFFFAOYSA-N |
| Synonyms | None reported |
As an accredited 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed amber glass vial containing 500 mg of 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile, labeled with safety and storage information. |
| Container Loading (20′ FCL) | Container loading (20′ FCL) for 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile ensures secure, bulk chemical shipment. |
| Shipping | This chemical is shipped in tightly sealed containers under ambient or controlled temperature conditions. Packaging ensures protection from moisture, light, and physical damage. All shipments comply with relevant chemical transport regulations, including appropriate hazard labeling and documentation, to ensure safe delivery. Handle with care upon receipt and store according to safety guidelines. |
| Storage | Store **4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile** in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizing agents. Follow all safety protocols, including the use of appropriate personal protective equipment (PPE). Store at room temperature unless specific conditions are noted on the SDS. |
| Shelf Life | Shelf life: Stable for at least 2 years when stored in a cool, dry place, away from light and moisture, in sealed container. |
|
Purity 98%: 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile with a purity of 98% is used in pharmaceutical intermediate synthesis, where it ensures high reaction yields and minimal impurity formation. Melting Point 210°C: 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile with a melting point of 210°C is used in solid dosage formulation, where it provides thermal stability during processing. Particle Size <10 µm: 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile with particle size below 10 µm is used in micronized active pharmaceutical ingredient production, where it enhances dissolution rates and bioavailability. Stability at pH 7.4: 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile with stability at pH 7.4 is used in physiological buffer applications, where it maintains consistent activity during biological assays. Moisture Content <0.5%: 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile with moisture content below 0.5% is used in moisture-sensitive formulations, where it prevents hydrolytic degradation. |
Competitive 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile in our facility draws on years of experience with heterocyclic chemistry, fluorinated building blocks, and advanced analytical control. Chemists in our plant recognize the unique synthetic challenges that often accompany nitrogen- and fluorine-rich aromatic compounds. The subtle interplay between fluorine location and ring chemistry defines both reactivity and physical properties. We have spent years refining our process to address hydrolysis propensity and minimize by-products that surface when handling halogenated pyridines alongside reactive cyano and hydroxy substituents.
Through direct feedback from our technical teams, we continually adjust reaction temperature profiles and purification methods, ensuring consistent product yield. The staff here works closely across R&D and quality control, troubleshooting the formation of side impurities that may emerge from trace water or uncontrolled microcrystallization during solvent exchange. Our chosen route yields a well-defined, free-flowing crystalline material, thanks to careful solvent selection and controlled temperature gradients during crystallization.
Selection of this compound typically starts with a need for robust aromatic platforms that support advanced pharmaceutical intermediate development. The 6-fluoropyridinyl substituent on the pyrazolopyridine framework creates a pi-stacking motif and balances lipophilicity with polarity. The hydroxy group at position 6 brings extra binding functionality. The nitrile at position 3 adds versatility, serving as a precursor for further modification or metal complexation.
Over the years, we noticed increased demand for building blocks that go beyond simple electronic or steric effects. Medicinal chemists and material scientists push for specificity, controlled reactivity, and the ability to easily derivatize for downstream targets. In response, we've focused on fine-tuning our product to meet realistic project deadlines, offering well-defined batches with consistently tight melting ranges, reliable elemental analysis, and rigorous chromatographic purity benchmarks.
Our operators see firsthand the moisture sensitivity of the raw intermediates. Crystal packing and polymorphism present manageable but critical variables in our drying protocols. Each batch run under controlled humidity and temperature environments, preventing surface degradation or unwanted de-fluorination. Packing staff verify free-flowing status visually and with flowability testing to avoid blockages in automated dispensing lines.
Batch data from the past year confirm high reproducibility in HPLC purity, typically above 99%. Powder X-ray diffraction checks rule out polymorph mixing. Users report minimal static clumping and easy transfer to weighing boats. Spectroscopic identity matches provided reference spectra generated with both NMR and FTIR in our own labs. We have iteratively reduced color impurities so that users get a pale, off-white solid that does not discolor on storage.
End users give regular feedback on ease of weighing, dissolution performance, and off-gassing risk. Chemists using traditional glassware or automated parallel synthesis platforms both report predictable handling, even with automated powder feeders. Our experience confirms that a clean, well-managed work environment with proper desiccation results in no detection of volatile amines or baseline drift in GC-MS.
Synthetic chemists often seek out this compound when planning the late-stage arylation or functionalization steps in targeted kinase inhibitor libraries and similar research projects. The combination of fluorine and nitrile in the same molecule brings a strong handle for palladium-catalyzed coupling conditions and robust click reactions. Several partners report the advantage of the hydroxy moiety for attachment of tethers in structure-activity relationship studies. In our direct supply relationships with discovery chemistry groups, we watch the product move from early hit exploration into more advanced scale-up and process route scouting.
Material scientists have used our compound to investigate optoelectronic effects from the strategic placement of heteroatoms. The electron-withdrawing character of the cyano group reduces HOMO energy levels for certain organic semiconductor prototypes. Our product finds a spot in custom dye and pigment projects where electron flow dynamics drive new optical performance. From our own production trials, we learned that minor tweaks to the crystallization protocol, along with extended drying cycles, eliminate formation of sticky agglomerates in these technically demanding applications.
In routine manufacturing, our chemists directly compare multiple pyrazolopyridine derivatives, some lacking hydroxy or fluoro substituents, others with methyl, chloro, or carboxyl groups. We observe that omitting the fluorine can sharply increase air and thermal sensitivity, while removing the nitrile often affects crystal habit and mechanical stability during filtration and transfer. Customers switching from more basic pyridine derivatives consistently mention improved selectivity and easier purification once they shift to our 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile.
Colleagues at oncology and anti-inflammatory drug startups run head-to-head reaction screens with this product and less electron-deficient analogues. In several cases, the fluoro group at the 6-position drives higher selectivity without elevating non-specific reactivity. Our team routinely optimizes the purity above the industry average, eliminating issues such as low-level halide contamination or batch cross-contamination found elsewhere.
Traditional halogenated pyridines often arrive with odorous or colored process impurities from less controlled syntheses. By contrast, our strict in-process analytical controls and the experience of our filtration teams limit such problems and result in a more stable, consistently white-to-off-white product. This attention to detail matters, especially for early-stage pharmaceutical route scouting where each impurity or physical defect can derail downstream progress.
Scientific teams speak up about the pressure to deliver new molecular candidates under tight conditions and unpredictable budgets. From our manufacturing vantage point, the more nuanced appreciation for product quality goes beyond numbers in the spec sheet. Receiving a benchmark-consistent batch week after week translates into less wasted development time and fewer failed scale-ups in the kilo lab or pilot plant settings. Every process engineer here understands the direct link between tight crystallization and drying control and field performance in medicinal chemistry campaigns.
Through direct dialogue with bench chemists, we also hear frequent reports that the robust packing and stability of our compound speeds up their internal logistics. Being able to store the product in standard lab containers instead of specialty ampoules saves money and eliminates bottlenecks for fast-moving teams. We focus on feedback from process and analytical chemistry specialists, many of whom tell us that the spectral purity and the absence of minor by-products reduces the need for additional column chromatography or recrystallization—freeing research teams to focus on new science instead of rework.
Documenting every step matters. Each batch of our 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile carries an unbroken record of raw material sourcing, reaction condition control, intermediate testing, and final release checks using NMR, HPLC, and IR. Our production chemists annotate unexpected shifts in polyphasic crystallization as part of batch records. If a melting point varies from historical trends, the entire process review team reassesses sample handling and environmental conditions.
Support and analysis teams keep every raw data record for external audit and internal troubleshooting. Users want transparency on product origin, and our teams build direct relationships with technical contacts at customer sites to answer specific questions on crystallinity, particle size, or residual solvent histories. Investing in high-resolution NMR and advanced purity screening tools over the years means our customers experience tighter lot-to-lot reproducibility and confidence when trouble emerges between synthetic steps.
Producing this compound hasn’t always been straightforward. Volatility of intermediates prone to oxidation forced our process team to reconfigure aeration and exhaust systems in synthesis halls. In the early days, minor leaks and over-drying in final steps produced difficult-to-handle, static-laden powders. Out of that challenge came antistatic handling procedures and new stainless-steel mesh filters that cut down on product loss.
Scaling up purification from gram to kilogram quantities amplified issues like slurry formation and filter clogging. Our team worked out staged solvent addition and slow filtration approaches, lowering batch failures. Analytical chemists flagged several times where off-target by-products popped up under certain humidity or batch age conditions, driving us to fine-tune hygroscopicity controls. It took real fieldwork and material science knowledge to stabilize the product’s shelf life so that formulation chemists could safely store it across seasons.
By producing and supporting this advanced heterocycle on an ongoing basis, we join a network that feeds both academic discovery and commercial translation. Contract research organizations, start-up medicinal chemistry groups, and specialty materials R&D teams all look for more than transactional supply—they look for problem-solving partners who recognize downstream bottlenecks and address them before they reach a customer lab. Our manufacturing floor becomes a direct extension of their synthesis bench.
Field feedback spurred us to create technical support materials grounded in real synthetic use. Instead of generic advice, we update guides to reflect new data from customer test reactions: changes in solvent solubility with temperature, best choices for filtration media, or unexplained reactivity trends with certain catalysts. The result shows up in fewer stoppages, greater batch-to-batch predictability, and a stronger relationship with applied chemistry teams trying to bring new molecular entities forward.
Tough moments crop up often in the scale-up lab—unexpected batch color, unforeseen hygroscopicity, solid-state transformations under long-term storage, or sparking electrostatic discharge during transfer. We fix these not by chasing quick protocol changes, but through repeated bench trials, operator training, and robust sample archiving. Each setback feeds into refining the process and updating SOPs regularly. Our staff meetings invite process engineers, chemists, and QC techs to hash out recurring bottlenecks and brainstorm practical tweaks, whether it means a new drying cycle protocol, an adjusted sieve mesh, or a new solvent exchange order.
Direct visits from end users encourage mutual learning. Customers running pilot reactions under different conditions sometimes spot edge-case incompatibilities our own teams miss—a rare NMR impurity, for instance, or a reaction inhibition trend with certain bases. We take these lessons back to our bench and adapt, tweaking synthetic routes or raising our own internal analytical thresholds. With every iteration, our batch reports improve, offering a living record grounded in the give-and-take between experienced production teams and innovative researchers.
A vision for chemistry that puts utility and trust above buzzwords depends on steady, real-world improvement. Careful management of 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile production stands as a quiet example of how decades of routine, attention to operator know-how, and honest troubleshooting build an exceptionally reliable product. This approach rewards both sides—the chemists at our plant and the teams carrying out demanding discovery research.
Colleagues in quality assurance often remind us that a transparent feedback loop—built from user experience, practical benchmarks, and solid batch history documentation—serves as the surest foundation for lasting value. Rather than chase fleeting trends or lowest-cost shortcuts, our plant adopts robust safety, traceability, and consistency standards. The lesson holds true across scales: what serves the process chemist at 10 grams ultimately makes the difference at the hundred-gram or kilo scale. Each lot improves because every challenge pushes us to refine, adapt, and remember that our work supports real progress in the working labs of our colleagues and customers.
Through years of focused work, listening to customer labs, and constant attention to bench chemistry realities, our production team keeps strengthening the value of this key building block for current and future science projects. Every procedural update, analytical review, and cycle of user dialogue grows our understanding. With each shipment, we aim to back up the hands-on scientist’s confidence that their material will not just meet a spec, but empower the next idea, synthesis, or technology advance. By treating production as a dynamic process—rooted in real chemistry and lived manufacturing practice—we continue to provide a benchmark heterocycle that stands out where it counts: in the hands of working chemists, solving real-world challenges, and building tomorrow’s solutions, one batch at a time.